Prediabetic insulin resistance is not permissive to the development of cardiac resistance to insulin-like growth factor I in ventricular myocytes

被引:26
|
作者
Hintz, KK [1 ]
Ren, J [1 ]
机构
[1] Univ N Dakota, Sch Med, Dept Physiol Pharmacol & Therapeut, Grand Forks, ND 58203 USA
关键词
IGF-1; insulin resistance; ventricular myocyte; cell shortening; Ca2+ transient;
D O I
10.1016/S0168-8227(01)00323-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Resistance to insulin-like growth factor I (IGF-1)-induccd cardiac contractile response has been reported in diabetes. To evaluate the role of prediabetic insulin resistance to cardiac IGF-1 resistance, whole body insulin resistance was generated with dietary sucrose and contractile function was evaluated in ventricular rnyocytes. Mechanical properties were evaluated using an lonOptix(TM) system and intracellular Ca2+ transients were measured as changes in fura-2 fluorescence intensity (DeltaFFI). After 8 weeks of feeding, sucrose rats displayed euglycemia, hepatomeglay and normal heart size, and glucose intolerance, confirming the presence of insulin resistance. Myocytes from sucrose-fed rats displayed decreased peak shortening (PS), reduced resting FFI, increased intracellular Ca2+ clearing, associated with normal duration of shortening and relengthening compared to myocytes from starch-fed rats. IGF-1 (10(-10) 10(-6) M) caused a similar concentration-dependent decrease in PS in both groups. Only the highest concentration of IGF-1 elicited an inhibition on DeltaFFI in Sucrose myocytes. In addition, the IGF-1-induced response was abolished by the IGF-1 receptor antagonist H-1356 in both groups, and by the nitric oxide synthase inhibitor L-NAME in starch but not sucrose myocytes. These results indicated prediabetic insulin resistance alters cardiac contractile function at the myocytes level, but may not be permissive to cardiac contractile resistance to IGF-1. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 50 条
  • [31] The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer
    Lann, Danielle
    LeRoith, Derek
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2008, 13 (04) : 371 - 379
  • [32] Insulin resistance in Laron syndrome (Primary insulin-like growth factor-I (IGF-I) deficiency) and effect of IGF-I replacement therapy
    Laron, Z
    Avitzur, Y
    Klinger, B
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 : 105 - 115
  • [33] Recombinant human insulin-like growth factor as a therapeutic agent for severe insulin resistance and type II diabetes mellitus
    Moses, AC
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 : 123 - 130
  • [34] microRNA-4458 Regulates Insulin Resistance in Hepatic Cells by Targeting the Insulin-Like Growth Factor 1 Receptor
    Zhou, Jingjing
    Zhu, Wenjuan
    Mao, Zheng
    Li, Zhen
    Li, Xiaoqin
    Cui, Fan
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (09) : 1812 - 1817
  • [35] Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor
    Sherajee, Shamshad J.
    Fujita, Yoshiko
    Rafiq, Kazi
    Nakano, Daisuke
    Mori, Hirohito
    Masaki, Tsutomu
    Hara, Taiga
    Kohno, Masakazu
    Nishiyama, Akira
    Hitomi, Hirofumi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 257 - U193
  • [36] In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1
    Jafari, Elham
    Gheysarzadeh, Ali
    Mahnam, Karim
    Shahmohammadi, Rezvan
    Ansari, Amir
    Bakhtyari, Hadi
    Mofid, Mohammad Reza
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2018, 13 (04) : 332 - 342
  • [37] The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance
    Himoto, Takashi
    Tani, Joji
    Miyoshi, Hisaaki
    Yoneyama, Hirohito
    Mori, Hirohito
    Inukai, Michio
    Masugata, Hisashi
    Goda, Fuminori
    Senda, Shoichi
    Haba, Reiji
    Masaki, Tsutomu
    NUTRITION RESEARCH, 2013, 33 (01) : 27 - 33
  • [38] INSULIN-LIKE GROWTH-FACTOR-I RESISTANCE IN PERIPHERAL TISSUE BUT NOT IN LIVER IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
    TOMINAGA, M
    YAMATANI, K
    IGARASHI, M
    EGUCHI, H
    DAIMON, M
    SEKIKAWA, A
    SASAKI, H
    ENDOCRINE JOURNAL, 1995, 42 (03) : 397 - 403
  • [39] Insulin-like growth factor I as a cardiac hormone: Physiological and pathophysiological implications in heart disease
    Ren, J
    Samson, WK
    Sowers, JR
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (11) : 2049 - 2061
  • [40] Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma
    Malin, A
    Dai, Q
    Yu, H
    Shu, XO
    Jin, F
    Gao, YT
    Zheng, W
    CANCER, 2004, 100 (04) : 694 - 700